https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 The effectiveness of natalizumab vs fingolimod - A comparison of international registry studies https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:38113 Wed 04 Aug 2021 11:40:28 AEST ]]> Prediction of multiple sclerosis outcomes when switching to ocrelizumab https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:46515 Thu 24 Nov 2022 15:50:23 AEDT ]]> Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:50986 Mon 14 Aug 2023 15:59:28 AEST ]]> Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:53931 Fri 22 Mar 2024 08:23:10 AEDT ]]>